Antenatal corticosteroids for early preterm birth: implementation strategy lessons from the WHO ACTION-I trial

Antenatal corticosteroids for early preterm birth: implementation strategy lessons from the WHO ACTION-I trial

Abstract The WHO ACTION-I trial, the largest placebo-controlled trial on antenatal corticosteroids (ACS) efficacy and safety to date, reaffirmed the benefits of ACS on mortality reduction among early preterm newborns in low-income settings. We discuss here lessons learned from ACTION-I trial that ar...

Full description

Bibliographic Details
Main Authors: Ayesha De Costa, Olufemi T. Oladapo, Shuchita Gupta, Anayda Portela, Joshua P. Vogel, Joao Paulo Souza, Suman Rao, Nicole Minckas, Özge Tuncalp, Rajiv Bahl, Fernando Althabe
Format: Article
Language:English
Published: BMC 2022-12-01
Series:Health Research Policy and Systems
Subjects:
Preterm birth
Neonatal mortality
Antenatal corticosteroids
Online Access:https://doi.org/10.1186/s12961-022-00941-z

Internet

https://doi.org/10.1186/s12961-022-00941-z

Similar Items